Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(24 sites)
Russia
RZD Medicine hospital, Barnaul, Altayskiy Kray V.F. Dolgopolov Vyselki Central District Hospital, Vyselki, Krasnodarskiy Kray Asinovskaya District Hospital, Asino, Tomsk Oblast Belgorod Regional Clinical Hospital of St. Joseph, Belgorod Kuzbass Cardiology center, Kemerovo Center of Neurology and Cardiology, Kirov Regional Clinical Hospital №2, Krasnodar Lipetsk City Hospital No. 4 "Lipetsk-Med", Lipetsk F.I. Inozemtsev City Clinical Hospital, Moscow Moscow Multidisciplinary Clinical Center "Kommunarka", Moscow S.S. Yudin City Clinical Hospital, Moscow V.M. Buyanov City Clinical Hospital, Moscow S.P. Botkin City Clinical Hospital, Moscow N.A. Semashko Nizhny Novgorod Regional Clinical Hospital, Nizhny Novgorod N.N. Burdenko Penza Regional Clinical hospital, Penza G.A. Zakharyin Clinical hospital №6, Penza City Clinical Hospital №4, Perm City Hospital No. 26, Saint Petersburg City Hospital No. 15, Saint Petersburg V.P. Polyakov Samara Regional Clinical Cardiology Dispensary, Samara Tomsk regional cilinical hospital, Tomsk Tver Regional Clinical Hospital, Tver' Ufa Emergency City Hospital, Ufa City Clinical Hospital of Emergency medicine №25, Volgograd